References
- Lu-Yao, G.L., et al., An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team. Jama 269(20):2633-2636. 1993.
- Walsh, P.C., A.W. Partin, J.I. Epstein. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 152(5 Pt 2):1831-1836. 1994.
- Isaacs, J.T., et al. Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl 13(6):457-464. 1992.
- Janus, T.J., Kyritsis, A.P., Forman, A.D., Levin, V.A. Biology and treatment of gliomas. Ann Oncol 3(6):423-433. Review, 1992.
- Yoshida, T., Kawano, N. Clinical cure of glioblastoma-two case reports. Neurol Med Chir (Tokyo), 40(4):224-229, 2000. https://doi.org/10.2176/nmc.40.224
- Madajewicz, S., Chowhan, N. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer 88(10):2350-2356, 2000. https://doi.org/10.1002/(SICI)1097-0142(20000515)88:10<2350::AID-CNCR20>3.0.CO;2-R
- Luper, S. A review of plants used in the treatment of liver disease L Part 1. Altern Med Rev 3, 410-421, 1998.
- Gershbein, L.L. Action of dietary trypsin, pressed coffee oil, silymarin and iron salt on 1,2-dimethylhydrazine tumorigenesis by gavage. Anticancer Res 14, 1113-1116, 1994.
- Katiyar, S.K., Korman, N.J., Mukhtar, H., Agarwal, R. Protective effects of silymarin against photocarcinogenesis in a mouse skin model. J Natl Cancer Inst 89, 556-566, 1997.
- Nehta, R.G., Moon, R.C. Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol. Anticancer Res 11, 593-596, 1991.
- Zi, X., Agarwal, R. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention. Proc Natl Acad Sci USA 96, 7490-7495, 1999.
- Zi, X., Zhang, J., Agarwal, R., Pollak, M. Silibinin upresgulates insulin-like growth factor-binding protein 3 expression and inhibits proliferation of androgen-independent prostate cancer cells. Cancer Res 60, 5617-5620, 2000.
- Zi, X., Grasso, A.W., Kung, H.J., Agarwal, R. A flavonoid antioxidant, silymarin, inhibits activation of erb B1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticacinogenic effects in human prostate carcinoma DU145 cells. Cancer Res 58, 1920-1929, 1998.
- Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254, 1976.
- Yanaida, Y., Kohno, H., Yoshida, K. et al. Dietary silymarin suppresses 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in male F344 rats. Carcino-genesis 23, 787-794, 2002.
- Vinh, P.Q., Sugie, S., Tanaka, T. et al. Chemopreventive effects of a flavonoid antioxidant silymarin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice. Jpn J Cancer Res 93, 42-49, 2002.
- Kohno, H., Tanaka, T., Kawabata, K. et al. Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer 101, 461-468, 2001.
- Goldberg, Y.P. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract, Nature Genetics 13, 442-449, 1996.
- Kim, T.W., Warren, H., Jung, Y.K., Kovacs, D., Tanzi, R. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease, Science 277, 373-376, 1997.
- Takahashi, A. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzymerelated proteases with distinct substrate recognition properties are active in apoptosis, Proc Natl Acad Sci USA 93, 8395-8400, 1996.
- Lazebnik, Y.A. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE, Nature 371,346-347, 1994.
- Wang, Z.Q. Mice lacking ADPRT and poly (ADP-ribosyl) ation develop normally but are susceptable to skin disease, Genes Dev 9, 509-520, 1995.
- Chakraborty, M. et al. Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression. Cancer Res 61(19):7255-7263, 2001.
- Gurumurthy, S., K.M. Vasudevan, V.M. Rangnekar. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev, 20(3-4):225-243, 2001.